We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+16.8%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$2.63B
AUM Growth
+$690M
Cap. Flow
+$451M
Cap. Flow %
17.16%
Top 10 Hldgs %
21.75%
Holding
1,066
New
264
Increased
497
Reduced
181
Closed
122

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$21.1M
2
MTCH icon
Match Group
MTCH
+$16.7M
3
AMZN icon
Amazon
AMZN
+$15.3M
4
MELI icon
Mercado Libre
MELI
+$13.9M
5
PDD icon
Pinduoduo
PDD
+$13.6M

Top Sells

Rank Stock Value
1
BBBY
Bed Bath & Beyond
BBBY
+$16M
2
PPLI
People Inc
PPLI
+$7.82M
3
ZM icon
Zoom
ZM
+$7.6M
4
KLAC icon
KLA
KLAC
+$7.1M
5
WUBA
58.com Inc
WUBA
+$6.96M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 35.11%
2 Technology 20.8%
3 Communication Services 14.79%
4 Industrials 4.05%
5 Financials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LAD icon
851
Lithia Motors
LAD
$8.26B
$7K ﹤0.01%
34
+4
+13% +$900
PSNL icon
852
Personalis
PSNL
$1.51B
$7K ﹤0.01%
+330
New +$6.56K
PETQ
853
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$7K ﹤0.01%
+214
New +$7.13K
COLL icon
854
Collegium Pharmaceutical
COLL
$956M
$6K ﹤0.01%
+296
New +$5.34K
PTGX icon
855
Protagonist Therapeutics
PTGX
$9.44B
$6K ﹤0.01%
+316
New +$5.93K
ENDP
856
DELISTED
Endo International plc
ENDP
$6K ﹤0.01%
+1,960
New +$6.29K
AN icon
857
AutoNation
AN
$6.92B
$5K ﹤0.01%
102
+12
+13% +$625
BCRX icon
858
BioCryst Pharmaceuticals
BCRX
$2.4B
$5K ﹤0.01%
+1,506
New +$6.45K
OMER icon
859
Omeros
OMER
$959M
$5K ﹤0.01%
+532
New +$6.85K
PGEN icon
860
Precigen
PGEN
$2.59B
$5K ﹤0.01%
+1,472
New +$6.99K
EGRX
861
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$5K ﹤0.01%
+118
New +$5.16K
IMGN
862
DELISTED
Immunogen Inc
IMGN
$5K ﹤0.01%
+1,490
New +$6.02K
SPPI
863
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$5K ﹤0.01%
+1,246
New +$4.74K
ONDK
864
DELISTED
On Deck Capital, Inc.
ONDK
$5K ﹤0.01%
3,180
-4,782
-60% -$6.48K
ASMB icon
865
Assembly Biosciences
ASMB
$529M
$4K ﹤0.01%
+23
New +$5.79K
GERN icon
866
Geron
GERN
$949M
$4K ﹤0.01%
+2,652
New +$4.91K
MGTX icon
867
MeiraGTx Holdings
MGTX
$1.21B
$4K ﹤0.01%
+318
New +$4.19K
MSA icon
868
Mine Safety
MSA
$7.49B
$4K ﹤0.01%
34
+4
+13% +$490
SIGA icon
869
SIGA Technologies
SIGA
$219M
$4K ﹤0.01%
+666
New +$4.53K
SRRK icon
870
Scholar Rock
SRRK
$6.44B
$4K ﹤0.01%
+256
New +$3.81K
VNDA icon
871
Vanda Pharmaceuticals
VNDA
$302M
$4K ﹤0.01%
+466
New +$4.98K
XBIT icon
872
XBiotech
XBIT
$69.2M
$4K ﹤0.01%
+248
New +$4.28K
QTTB icon
873
Q32 Bio
QTTB
$464M
$4K ﹤0.01%
+21
New +$4.71K
TECX
874
Tectonic Therapeutic
TECX
$606M
$4K ﹤0.01%
+26
New +$5.24K
CBAY
875
DELISTED
Cymabay Therapeutics
CBAY
$4K ﹤0.01%
+586
New +$3.13K
33 34
35
36 37

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Penserra Capital Management held 1,066 positions worth $2.63B, up 36% from $1.94B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Penserra Capital Management deployed $451M of net new capital in Q3 2020, opening 264 new positions and adding to 497 existing holdings. Its largest new stake was Match Group: 157,606 shares worth $17.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, up from 29% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Bed Bath & Beyond, an estimated $16M trimmed.

  • Penserra Capital Management's largest Q3 2020 buy was Match Group: 157,606 shares worth $17.4M.
  • Penserra Capital Management added most to Alibaba in Q3 2020, an estimated $21.1M increase.
  • Penserra Capital Management's biggest Q3 2020 reduction was Bed Bath & Beyond, cutting an estimated $16M.
  • Penserra Capital Management fully exited 58.com Inc in Q3 2020, selling an estimated $6.96M.
  • Penserra Capital Management's ten largest holdings make up 22% of its $2.63B portfolio in Q3 2020.
  • Penserra Capital Management opened 264 new positions and closed 122 in Q3 2020.
  • Penserra Capital Management's portfolio value rose 36% quarter-over-quarter to $2.63B.

Based on Penserra Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.